A detailed history of Emerald Advisers, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Emerald Advisers, LLC holds 150,907 shares of TMDX stock, worth $9.64 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
150,907
Previous 323,350 53.33%
Holding current value
$9.64 Million
Previous $48.7 Million 51.35%
% of portfolio
0.99%
Previous 2.18%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$135.68 - $176.11 $23.4 Million - $30.4 Million
-172,443 Reduced 53.33%
150,907 $23.7 Million
Q2 2024

Aug 06, 2024

SELL
$72.62 - $150.62 $14.5 Million - $30.1 Million
-200,070 Reduced 38.22%
323,350 $48.7 Million
Q1 2024

May 08, 2024

BUY
$70.86 - $89.93 $500,767 - $635,535
7,067 Added 1.37%
523,420 $38.7 Million
Q4 2023

Feb 05, 2024

BUY
$36.74 - $81.08 $2.71 Million - $5.98 Million
73,807 Added 16.68%
516,353 $40.8 Million
Q3 2023

Oct 26, 2023

BUY
$53.47 - $96.07 $345,041 - $619,939
6,453 Added 1.48%
442,546 $24.2 Million
Q2 2023

Jul 25, 2023

BUY
$66.23 - $88.73 $366,980 - $491,652
5,541 Added 1.29%
436,093 $36.6 Million
Q1 2023

May 04, 2023

SELL
$53.63 - $82.33 $7.09 Million - $10.9 Million
-132,115 Reduced 23.48%
430,552 $32.6 Million
Q4 2022

Feb 03, 2023

BUY
$39.08 - $64.29 $2.65 Million - $4.36 Million
67,741 Added 13.69%
562,667 $34.7 Million
Q3 2022

Oct 25, 2022

BUY
$31.56 - $55.75 $3.07 Million - $5.43 Million
97,361 Added 24.49%
494,926 $20.7 Million
Q2 2022

Jul 29, 2022

BUY
$20.56 - $32.15 $2.4 Million - $3.75 Million
116,612 Added 41.51%
397,565 $12.5 Million
Q1 2022

Apr 29, 2022

BUY
$12.58 - $26.94 $454,603 - $973,530
36,137 Added 14.76%
280,953 $7.57 Million
Q4 2021

Feb 02, 2022

SELL
$19.16 - $32.68 $164,047 - $279,806
-8,562 Reduced 3.38%
244,816 $4.69 Million
Q3 2021

Oct 28, 2021

SELL
$25.92 - $34.51 $1.22 Million - $1.62 Million
-47,086 Reduced 15.67%
253,378 $8.38 Million
Q2 2021

Jul 29, 2021

SELL
$21.63 - $40.07 $6.59 Million - $12.2 Million
-304,511 Reduced 50.33%
300,464 $9.97 Million
Q1 2021

Apr 29, 2021

SELL
$17.75 - $47.82 $1.21 Million - $3.25 Million
-67,905 Reduced 10.09%
604,975 $25.1 Million
Q4 2020

Jan 29, 2021

BUY
$11.91 - $19.9 $258,411 - $431,770
21,697 Added 3.33%
672,880 $13.4 Million
Q3 2020

Oct 28, 2020

SELL
$13.78 - $18.84 $251,953 - $344,470
-18,284 Reduced 2.73%
651,183 $8.97 Million
Q2 2020

Jul 28, 2020

BUY
$11.66 - $18.26 $2.52 Million - $3.95 Million
216,389 Added 47.76%
669,467 $12 Million
Q1 2020

Apr 30, 2020

BUY
$10.5 - $20.2 $16,128 - $31,027
1,536 Added 0.34%
453,078 $5.47 Million
Q4 2019

Jan 29, 2020

BUY
$16.61 - $21.64 $4.04 Million - $5.26 Million
243,034 Added 116.56%
451,542 $8.58 Million
Q3 2019

Oct 31, 2019

SELL
$20.27 - $28.93 $60,810 - $86,790
-3,000 Reduced 1.42%
208,508 $4.95 Million
Q2 2019

Jul 31, 2019

BUY
$22.36 - $30.41 $4.73 Million - $6.43 Million
211,508 New
211,508 $6.13 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.03B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Emerald Advisers, LLC Portfolio

Follow Emerald Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.